journal article·2022-05-04

Tetrahedral Framework Nucleic Acids Connected with MicroRNA-126 Mimics for Applications in Vascular Inflammation, Remodeling, and Homeostasis

Yichen Ge, Qingxuan Wang, Xin Qin, Songhang Li, Zhiqiang Liu, Yunfeng Lin, Xiaobing Li, Xiaoxiao Cai

ACS Applied Materials & Interfaces· Volume 14· Issue 17
Publisher page

Abstract

The repair of damaged endothelium is crucial for vascular homeostasis maintenance, which comprises the recovery of early stage impaired endothelial cells and migration of surrounding unimpaired endothelial cells. MicroRNAs (miRNAs) play an indispensable role in balancing gene expression in organisms. For vascular tissues, miR-126 is one of the most important regulators and might have substantial application potential in maintaining vascular homeostasis. In this study, a type of sticky-end-modified tetrahedral framework nucleic acids (tFNAs-SE) was employed to successfully link the miR-126 5p mimic duplex, which was termed tFNAs-miR-126 5p mimics (tFNAs-MMs). Existing vascular endothelial growth factors (VEGF), tFNAs-MMs can improve cell viability, resist apoptosis, and recover the state and functions of LPS-induced impaired human umbilical vein endothelial cells (HUVECs). The angiogenesis ability of impaired HUVECs was recovered by tFNAs-MMs in vitro and in vivo. The mechanisms underlying these phenomena were demonstrated to be related to the downregulation of caspase3 and negative regulators of VEGF (SPRED1 and PIK3R2). Moreover, tFNAs-MMs promoted the migration and proliferation of HUVECs. Briefly, the strategy of sticky-end-modified tFNAs connecting miRNA mimics is available for miRNA gain of function, while tFNAs-MMs might be a promising agent for repairing early stage vascular damage and maintaining vascular homeostasis.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: MicroRNA in disease regulation · RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan 610041, China

Funding

Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China · Sichuan Province Youth Science and Technology Innovation Team

References (59)

Show source-provided references
1. 10.1038/nature0447810.1038/nature04478 ↗
2. 10.1016/S1474-4422(19)30079-110.1016/S1474-4422(19)30079-1 ↗
3. 10.1055/s-0035-155658610.1055/s-0035-1556586 ↗
4. 10.1038/nri217110.1038/nri2171 ↗
5. 10.1186/s12872-015-0124-z10.1186/s12872-015-0124-z ↗
6. 10.1126/science.106492110.1126/science.1064921 ↗
7. 10.1016/j.biotechadv.2019.04.01210.1016/j.biotechadv.2019.04.012 ↗
8. 10.1016/S0092-8674(04)00045-510.1016/S0092-8674(04)00045-5 ↗
9. 10.1038/nrg132810.1038/nrg1328 ↗
10. 10.1016/j.cell.2005.11.02310.1016/j.cell.2005.11.023 ↗
11. 10.2174/138161282666620050412073710.2174/1381612826666200504120737 ↗
12. 10.2174/1570161111311999001710.2174/15701611113119990017 ↗
13. 10.1007/978-1-60761-863-8_1510.1007/978-1-60761-863-8_15 ↗
14. 10.3390/cells901013710.3390/cells9010137 ↗
15. 10.1002/adma.20210782010.1002/adma.202107820 ↗
16. 10.1038/s41392-021-00727-910.1038/s41392-021-00727-9 ↗
17. 10.1021/acs.nanolett.0c0052910.1021/acs.nanolett.0c00529 ↗
18. 10.1021/acs.nanolett.9b0132010.1021/acs.nanolett.9b01320 ↗
19. 10.1002/adfm.20200734210.1002/adfm.202007342 ↗
20. 10.1002/anie.20140323610.1002/anie.201403236 ↗
21. 10.1038/s41596-020-0355-z10.1038/s41596-020-0355-z ↗
22. 10.1002/smll.20210435910.1002/smll.202104359 ↗
23. 10.1093/nar/gkz64510.1093/nar/gkz645 ↗
24. 10.1021/nl402628n10.1021/nl402628n ↗
25. 10.1152/ajpcell.00313.201810.1152/ajpcell.00313.2018 ↗
26. 10.1007/978-1-4939-7477-1_910.1007/978-1-4939-7477-1_9 ↗
27. 10.1038/s41420-020-00349-010.1038/s41420-020-00349-0 ↗
28. 10.1021/acsami.0c1730710.1021/acsami.0c17307 ↗
29. 10.1080/08941939.2018.152983910.1080/08941939.2018.1529839 ↗
30. 10.3109/07435800.2015.111016210.3109/07435800.2015.1110162 ↗
31. 10.1038/nprot.2010.610.1038/nprot.2010.6 ↗
32. 10.1007/s10456-009-9146-410.1007/s10456-009-9146-4 ↗
33. 10.1016/j.yjmcc.2016.05.00710.1016/j.yjmcc.2016.05.007 ↗
34. 10.1111/jcmm.1672710.1111/jcmm.16727 ↗
35. 10.1016/j.yjmcc.2012.04.00310.1016/j.yjmcc.2012.04.003 ↗
36. 10.1016/j.devcel.2008.07.00210.1016/j.devcel.2008.07.002 ↗
37. 10.1016/j.biopha.2019.10953810.1016/j.biopha.2019.109538 ↗
38. 10.3791/5152510.3791/51525 ↗
39. 10.2174/18715290878584907110.2174/187152908785849071 ↗
40. 10.1007/s00018-014-1678-010.1007/s00018-014-1678-0 ↗
41. 10.1016/j.bbrc.2020.02.13710.1016/j.bbrc.2020.02.137 ↗
42. 10.1016/j.mvr.2016.02.00410.1016/j.mvr.2016.02.004 ↗
43. 10.1080/15384101.2020.176939410.1080/15384101.2020.1769394 ↗
44. 10.1016/j.biopha.2019.10900710.1016/j.biopha.2019.109007 ↗
45. 10.26355/eurrev_201904_1758810.26355/eurrev_201904_17588 ↗
46. 10.1016/j.bbadis.2011.02.00210.1016/j.bbadis.2011.02.002 ↗
47. 10.1021/acsami.1c0928110.1021/acsami.1c09281 ↗
48. 10.1002/adma.20200370810.1002/adma.202003708 ↗
49. 10.1002/adma.20210960910.1002/adma.202109609 ↗
50. 10.1002/adfm.20210972810.1002/adfm.202109728 ↗
51. 10.1021/acsnano.1c0962610.1021/acsnano.1c09626 ↗
52. 10.1016/j.bioactmat.2021.06.00310.1016/j.bioactmat.2021.06.003 ↗
53. 10.1021/acs.nanolett.1c0500310.1021/acs.nanolett.1c05003 ↗
54. 10.1016/j.cej.2022.13485510.1016/j.cej.2022.134855 ↗
55. 10.1016/j.bioactmat.2021.11.03110.1016/j.bioactmat.2021.11.031 ↗
56. 10.1016/j.bioactmat.2020.11.01810.1016/j.bioactmat.2020.11.018 ↗
57. 10.3390/cells802017110.3390/cells8020171 ↗
58. 10.1007/978-1-4939-9133-4_1810.1007/978-1-4939-9133-4_18 ↗
59. 10.1023/A:102150703148610.1023/A:1021507031486 ↗